Discover open access scientific publications

Search, annotate, share and cite publications

Publications in Respiratory Medicine

MA02.03 ASTRIS: A Real World Treatment Study of Osimertinib in Patients With EGFR T790m-Positive NSCLC

Journal of Thoracic Oncology

English

P1.13-24 EGFR-KDD Is Rare and Demonstrates Variable Anti-Tumor Response to Tyrosine Kinase Inhibitors in East Asian NSCLC Population

Journal of Thoracic Oncology

English

MS32.04 Molecular Phenotypes of SCLC

Journal of Thoracic Oncology

English

S22 Lung Clearance Index, FEV1 and CT Findings in Cystic Fibrosis: Data From the UK CF Gene Therapy Consortium Run-In Study

English

P2.04-10 Early Monitoring of Blood Biomarkers to Predict Nivolumab Efficacy in NSCLC Patients

Journal of Thoracic Oncology

English

P2.06-02 Feasibility of Intensity Modulated Radiotherapy After Pleurectomy/Decortication for Malignant Pleural Mesothelioma Patients

Journal of Thoracic Oncology

English

P2.11-20 Lung EpiCheck TM - Results of the Training and Test Sets of a Methylation-Based Blood Test for Early Detection of Lung Cancer

Journal of Thoracic Oncology

English

P3.cr-03 Pulmonary Spindle Cell Neoplasm - Neoadjuvant Treatment and Response

Journal of Thoracic Oncology

English

P07 Preliminary Orthogonal Analysis of EML4-ALK Gene Fusion Detection Methods in Chilean Patients With Lung Adenocarcinoma

Journal of Thoracic Oncology

English

Combination of Crizotinib and Osimertinib or Erlotinib Might Overcome MET-Mediated Resistance to EGFR Tyrosine Kinase Inhibitor in EGFR-Mutated Adenocarcinoma

Journal of Thoracic Oncology

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications in Respiratory Medicine

MA02.03 ASTRIS: A Real World Treatment Study of Osimertinib in Patients With EGFR T790m-Positive NSCLC

P1.13-24 EGFR-KDD Is Rare and Demonstrates Variable Anti-Tumor Response to Tyrosine Kinase Inhibitors in East Asian NSCLC Population

MS32.04 Molecular Phenotypes of SCLC

S22 Lung Clearance Index, FEV1 and CT Findings in Cystic Fibrosis: Data From the UK CF Gene Therapy Consortium Run-In Study

P2.04-10 Early Monitoring of Blood Biomarkers to Predict Nivolumab Efficacy in NSCLC Patients

P2.06-02 Feasibility of Intensity Modulated Radiotherapy After Pleurectomy/Decortication for Malignant Pleural Mesothelioma Patients

P2.11-20 Lung EpiCheck TM - Results of the Training and Test Sets of a Methylation-Based Blood Test for Early Detection of Lung Cancer

P3.cr-03 Pulmonary Spindle Cell Neoplasm - Neoadjuvant Treatment and Response

P07 Preliminary Orthogonal Analysis of EML4-ALK Gene Fusion Detection Methods in Chilean Patients With Lung Adenocarcinoma

Combination of Crizotinib and Osimertinib or Erlotinib Might Overcome MET-Mediated Resistance to EGFR Tyrosine Kinase Inhibitor in EGFR-Mutated Adenocarcinoma